filter by theme Women's health Endocrinology Academic support Non clinical

Levonorgestrel-only emergency contraception: real-world tolerance and efficacy.

Gainer E, Méry C, Ulmann A.Contraception. 2001 Jul;64(1):17-21.

Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception.

Gainer E, Massai R, Lillo S, Reyes V, Forcelledo ML, Caviedes R, Villarroel C, Bouyer J.Hum Reprod. 2007 Jun;22(6):1578-84.

Linkage and mutational analysis of familial thyroid dysgenesis demonstrate genetic heterogeneity implicating novel genes.

Castanet M, Sura-Trueba S, Chauty A, Carré A, de Roux N, Heath S, Léger J, Lyonnet S, Czernichow P, Polak M.Eur J Hum Genet. 2005 Feb;13(2):232-9.

M909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins

Isabelle Petit-Topin, Nathalie Turque, Jérôme Fagart, André Ulmann, Erin Gainer and Marie-Edith Rafestin-OblinMol Pharmacol. Mol Pharmacol. 2009 Jun;75(6):1317-24. Epub 2009 Mar 16.

Menstrual bleeding patterns following levonorgestrel emergency contraception.

Gainer E, Kenfack B, Mboudou E, Doh AS, Bouyer J.Contraception. 2006 Aug;74(2):118-24.

Misoprostol: Why Gymiso?

Ulmann A.Gynecol Obstet Fertil. 2006 Oct;34(10):883-4.

Molecular mechanisms of thyroid dysgenesis.

Polak M, Sura-Trueba S, Chauty A, Szinnai G, Carré A, Castanet M.Horm Res. 2004;62 Suppl 3:14-21. Review.

Pharmacologic properties of CDB(VA)-2914.

Gainer EE, Ulmann A.Steroids. 2003 Nov;68(10-13):1005-11.